Want to join the conversation?
$PFE said it has published new analysis of data from 3 VYNDAQEL studies in patients with mild transthyretin familial amyloid polyneuropathy. The analysis showed that VYNDAQEL treatment during early disease stage resulted in minimal neurological disease progression and in preservation of body weight, which often declines as disease progresses.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.